Description of a randomised controlled trial of inhaled corticosteroid/fast-onset LABA reliever therapy in mild asthma

This paper describes the rationale and design of the Novel START (Symbicort Turbuhaler Asthma Reliever Therapy) randomised controlled trial of inhaled corticosteroid (ICS)/fast-onset long-acting β-agonist (LABA) reliever therapy in mild asthma. Description of a real world study of the novel ICS/fast-onset LABA reliever therapy regimen in mild asthma